Use of kefir peptide for improving or treating depressive behaviors and related diseases
AssigneeNational Chung Hsing University
InventorsChuan-Mu Chen, Hsiao-Ling Chen
Life of this patent
Estimating the term…
Abstract
The invention discloses that a kefir peptide with an amino acid sequence of SEQ ID No: 2 or a fermentation product comprising the kefir peptide has an antidepressant activity, which means that by administering an effective amount of the kefir peptide or a composition comprising an effective amount of the kefir peptide to an individual with depressive behaviors is capable of effectively improving or alleviating the individual's depressive behaviors. Since the kefir peptide disclosed in the invention is not a chemical compound, the kefir peptide will not have side effects on the human body even taking it on a long-term basis.
Claims6
A method for treating depression, comprising administering an effective amount of a composition to a subject in need thereof for enhancing an expression of brain-derived neurotrophic factor (BDNF) in hippocampal tissues of the subject and activating a BDNF/TrkB information channel, thereby improving or alleviating the depressive behaviors or symptoms of depression of the subject;
- wherein the composition comprises a purified kefir peptide, and an amino acid sequence of the kefir peptide comprises a sequence of SEQ ID No:
- 2.
Dependencies are inferred from the claim text.